Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
CA 2132012 C · Owner: Depomed Systems, Incorporated · Inventors: Shell, John W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Sustained release oral drug dosage forms that comprise a tablet or capsule of a plurality of particles of a solid-state drug dispersed in alkyl cellulose such as hydroxyethylcellulose or hydroxypropylcellulose. Once ingested the tablet or capsule disintegrates to disperse the particles into the stomach where they imbibe water to cause them to swell and also to become slippery thus, enhancing their retention in the stomach. Imbibed water from the gastric fluid dissolves the drug entrapped in the particles and the resulting solution diffuses from the dispersed particles assuring that no , solid drug, which is more irritating contacts the mu-, cosal tissue. A number of embodiments of the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 17, 1993 and granted April 22, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 17, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.